Investors are beginning to turn cautious on biotech stocks as a rapid rise in Treasury yields dents the appeal for shares of companies that are often viewed as risky all-or-nothing bets on breakthrough medical treatments
Investors will become more selective in the near future when it comes to IPOs, as rising concern about the spending on the AI expansion ripples across the market, according to Citi
Investors are becoming more discerning in a well-advanced AI boom. The result is a build-up of distress in the riskiest corner of the debt market, even as AI’s megacap winners’ shares rise.
Investors are betting UK Chancellor John Healey will stick to fiscal discipline in his first budget. James Smith from ING told Reuters the biggest surprises could come from better-than-expected forecasts but for markets, a boring budget may be just what the doctor ordered